BlossomHill Therapeutics to Present at the 8th Annual RAS-Targeted Drug Development Summit & H.C. Wainwright 28th Annual Global Investment Conference
BlossomHill Therapeutics will present at two September conferences: the 8th Annual RAS-Targeted Drug Development Summit at The Colonnade Hotel in Boston on September 10, and the H.C. Wainwright 28th Annual Global Investment Conference at the Lotte New York Palace Hotel on September 15. Chief Medical Officer Geoff Oxnard, M.D. presents at the RAS summit, while founder and CEO Jean Cui, Ph.D.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.